Supernus Pharmaceuticals, Inc. Balance Sheet
SUPN / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
Supernus Pharmaceuticals, Inc. had $1.5B in total assets and $1.1B in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $128.4M | $69.3M | $75.1M | $93.1M | $203.4M | $288.6M | $181.4M | $192.2M | $100.3M | $36.4M | $33.5M | $36.4M | $33.0M | $40.3M | $48.5M |
| Accounts Receivable | $187.8M | $142.1M | $144.2M | $165.5M | $148.9M | $140.9M | $87.3M | $67.2M | $65.6M | $41.5M | $25.9M | $17.3M | $5.1M | $11.0K | - |
| Inventory | $112.5M | $54.3M | $77.4M | $91.5M | $86.0M | $48.3M | $26.6M | $25.7M | $16.3M | $16.8M | $12.6M | $13.4M | $7.2M | $1.2M | - |
| Current Assets | $644.2M | $686.1M | $493.1M | $734.2M | $601.6M | $630.4M | $472.6M | $493.5M | $228.5M | $151.4M | $105.9M | $108.9M | $97.2M | $91.5M | $49.4M |
| PP&E (Net) | $10.5M | $11.5M | $13.5M | $15.2M | $17.0M | $37.8M | $17.1M | $4.1M | $5.1M | $4.3M | $3.9M | $2.4M | $2.6M | $1.4M | $1.3M |
| Goodwill | $124.9M | $117.0M | $117.0M | $117.0M | $117.5M | $77.9M | $0 | - | - | - | - | - | - | - | - |
| Total Assets | $1.5B | $1.4B | $1.3B | $1.7B | $1.7B | $1.5B | $1.2B | $977.8M | $424.5M | $309.6M | $188.6M | $137.5M | $111.0M | $94.0M | $53.7M |
| Current Liabilities | $338.2M | $292.4M | $290.2M | $688.0M | $315.4M | $245.1M | $160.6M | $161.4M | $123.0M | $80.7M | $56.9M | $27.5M | $26.4M | $23.0M | $18.8M |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | $23.2M | - |
| Shareholders' Equity | $1.1B | $1.0B | $921.5M | $886.2M | $815.9M | $744.9M | $595.4M | $191.8M | $88.0M | $40.7M | $88.0M | $40.7M | $33.5M | $57.6M | $9.4M |